Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass
Richard Gill, Taiyi Kuo
Richard Gill, Taiyi Kuo
View: Text | PDF
Research Article Endocrinology Metabolism

Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass

  • Text
  • PDF
Abstract

Obesity and type 2 diabetes (T2D) are metabolic diseases with increasing prevalence worldwide. Obesity often leads to T2D. Insulin resistance and impaired β cell function contribute to the onset of hyperglycemia. Previously, we reported that ablation of Gc, encoding a secreted protein with a primary role in vitamin D transport, improved pancreatic β cell function in models of diet-induced insulin resistance. Here, we show that Gc ablation had systemic insulin-sensitizing effects to prevent weight gain, hyperglycemia, and glucose intolerance; lower nonesterified fatty acids and triglycerides; and augment glucose uptake in skeletal muscle and adipose in male mice fed a high-fat diet. Interestingly, weight loss in Gc-ablated mice resulted from selective fat mass loss with preserved lean mass. Moreover, acute Gc inhibition prevented glucose intolerance caused by high-fat feeding. The data suggest that Gc inhibition can increase insulin production in β cells and insulin action in peripheral tissues, while reducing fat mass.

Authors

Richard Gill, Taiyi Kuo

×

Figure 6

Heatmaps and immunoblotting of WT and GcKO liver.

Options: View larger image (or click on image) Download as PowerPoint
Heatmaps and immunoblotting of WT and GcKO liver.
(A and B) HFD-fed WT a...
(A and B) HFD-fed WT and GcKO male mice were fasting for 16 hours (fasted condition), or fasted for 16 hours followed by 2 hours refeeding (refed condition), and subjected for RNA-Seq. Heatmaps represent top differentially expressed genes between refed WT (n = 3) versus refed GcKO (n = 4) (A) and fasted WT (n = 3) versus fasted GcKO (n = 5) mice (A), with TPM ≥ 1. The gray bar on the left highlighted genes of interest in red. (C) Immunoblotting in refed WT and GcKO liver with antibodies against Klf15, Cyp2e1, and GAPDH (internal control). (D) Quantification for Klf15 normalized to GAPDH in C. (E) Quantification of Cyp2e1 normalized to GAPDH in C. Data are shown as mean ± SEM, *P < 0.05, ***P < 0.005 by Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts